Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash from Operations (2021 - 2025)

Historic Cash from Operations for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $14.1 million.

  • Biote's Cash from Operations fell 953.97% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year increase of 40.67%. This contributed to the annual value of $45.2 million for FY2024, which is 6829.59% up from last year.
  • Biote's Cash from Operations amounted to $14.1 million in Q3 2025, which was down 953.97% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Biote's Cash from Operations ranged from a high of $17.9 million in Q2 2021 and a low of -$28.6 million during Q2 2022
  • For the 5-year period, Biote's Cash from Operations averaged around $6.5 million, with its median value being $7.0 million (2022).
  • In the last 5 years, Biote's Cash from Operations crashed by 25920.87% in 2022 and then surged by 962250.0% in 2024.
  • Quarter analysis of 5 years shows Biote's Cash from Operations stood at $10.1 million in 2021, then tumbled by 39.97% to $6.1 million in 2022, then grew by 14.96% to $7.0 million in 2023, then soared by 77.8% to $12.4 million in 2024, then rose by 13.78% to $14.1 million in 2025.
  • Its Cash from Operations stands at $14.1 million for Q3 2025, versus $7.1 million for Q2 2025 and $6.5 million for Q1 2025.